GlaxoSmithKline (GSK) has entered into a drug discovery alliance with Yale to design a potential new class of medicines that degrade disease-causing proteins. Under the collaboration, GSK integrates its expertise in medicinal chemistry ...
Tags: Yale University, Drug Discovery Alliance, protein-degrading drug
GlaxoSmithKline (GSK) and Chiromics have partnered to discover classes of small molecules against biological targets. The collaboration will leverage Chiromics' compound collections of accessible complexity, Chalis, hit recognition ...
Tags: biological targets, classes of Small Molecules, drug discovery
The Anti-Infective Drugs Advisory Committee to the US Food and Drug Administration (FDA) has supported the clinical benefit of GlaxoSmithKline's raxibacumab to treat inhalational anthrax. In addition, the committee also favoured the ...
Tags: The Anti-Infective Drugs, raxibacumab anti-toxin development programme
Ten biopharmaceutical companies, Abbott, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly and Company, GlaxoSmithKline, Johnson & Johnson, Pfizer, Genentech and Sanofi have established a non-profit organization ...
Tags: biopharmaceutical companies, non-profit organization, new medicines
GlaxoSmithKline's (GSK) Promacta has won FDA approval as thrombocytopenia therapy in chronic hepatitis C patients. Promacta, brand name of eltrombopag in the US, will enable thrombocytopenia patients suffering from chronic hepatitis C ...
Tags: FDA approval, thrombocytopenia therapy, chronic hepatitis C
An IT recruitment expert has criticised government pay thresholds for overseas IT workers in the UK, claiming it groups vastly different jobs together and sets salaries too low, presuming an IT director in the UK can earn as little as ...
Tags: IT workers, MAC, IT professionals, low-cost IT staff
Royal Sussex County Hospital says it hopes to save around £21,000 after replacing traditional fixtures with LEDs. Brighton and Sussex University Hospitals NHS Trust commissioned Light Planet to implement the changes within the ...
Tags: LED, Brighton Hospital, traditional fixture
GREATER Manchester-based MHA Lighting has scooped a top accolade for an innovative lighting product which is helping NHS Trusts fight hospital acquired infection rates. The Atherton-based lighting company fought off tough competition to ...
Tags: LED Lighting
Aquafresh Ultimate,the new''Whole Tooth Protection''flagship brand for GlaxoSmithKline(GSK),is the result of a close collaboration between GSK in-house PacXperience&Consumer Healthcare Futures and strategic brand innovation&design ...
Tags: Collaborate, GSK, collaboration
GlaxoSmithKline (GSK) has signed a definitive agreement to acquire Human Genome Sciences (HGS) for $14.25 per share in cash. The transaction values HGS at approximately $3.6bn on an equity basis, or approximately $3bn net of cash and ...
Tags: GSK, Human Genome Sciences, HGS
GlaxoSmithKline (GSK) and Theravance have announced the regulatory submissions for furoate FF/vilanterol VI (FF/VI) to treat chronic obstructive pulmonary disease (COPD) in the US and Europe. The companies also announced regulatory ...
GlaxoSmithKline (GSK) will pay $3bn, which includes a $1bn criminal fine and forfeiture and $2bn to resolve civil claims, in fine and will plead guilty for promoting antidepressants Paxil and Wellbutrin for unapproved uses. The largest ...
Tags: antidepressant, criminal fine, civil claim, health care fraud
The Corporate IT Forum Education and Skills Commission has condemned the UK Government's decision to scrap the ICT curriculum in schools from this September. Members of the commission,who include large corporations,educators and UK trade ...
Tags: ICT Curriculum, Computer Science, School
Ligand Pharmaceuticals partner GlaxoSmithKline has submitted regulatory applications in the US and European Union for the use of eltrombopag (Promacta/Revolade) to increase platelet counts in patients with hepatitis C. A supplemental ...
Genmab and GlaxoSmithKline (GSK) have announced the submission of a new drug application (NDA) for Arzerra (ofatumumab) to the Japanese Ministry of Health, Labor and Welfare (MHLW). Arzerra (ofatumumab) is submitted for the approval ...
Tags: new drug application, Arzerra, chronic lymphocytic leukemia